Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belinostat plus carboplatin and/or paclitaxel in advanced solid tumors
NCT00421889Phase 2Completed
- Sponsor
- Valerio Therapeutics
- Start
- Aug 2005
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of belinostat in ovarian cancer, epithelial ovarian cancer (EOC), fallopian tube cancer (PFTC), bladder cancer, primary peritoneal cancer (PPC), sponsored by Valerio Therapeutics. Started Aug 2005; status: completed.
02
Drugs
belinostat
03
Conditions
ovarian cancerepithelial ovarian cancer (EOC)fallopian tube cancer (PFTC)bladder cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00421889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421889.